<SEC-DOCUMENT>0001213900-24-085543.txt : 20241004
<SEC-HEADER>0001213900-24-085543.hdr.sgml : 20241004
<ACCEPTANCE-DATETIME>20241004160528
ACCESSION NUMBER:		0001213900-24-085543
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20241003
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241004
DATE AS OF CHANGE:		20241004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oruka Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		241354944

	BUSINESS ADDRESS:	
		STREET 1:		855 OAK GROVE AVE.
		STREET 2:		SUITE 100
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-606-7910

	MAIL ADDRESS:	
		STREET 1:		855 OAK GROVE AVE.
		STREET 2:		SUITE 100
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARCA biopharma, Inc.
		DATE OF NAME CHANGE:	20090128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0216746-8k_oruka.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ORKA="http://orukatx.com/20241003">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_ORKA_orukatx.com_20241003 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20241003_20241003 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0000907654 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000004" name="dei:EntityCentralIndexKey">0000907654</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="orka-20241003.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-10-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000907654</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-03</xbrli:startDate>
        <xbrli:endDate>2024-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>FORM <span id="xdx_902_edei--DocumentType_c20241003__20241003_zZ9APKpXx9c3"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of Earliest Event Reported):
<span id="xdx_907_edei--DocumentPeriodEndDate_c20241003__20241003_zv6aKI8ogvU8"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October 3, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityRegistrantName_c20241003__20241003_z2ewXqQ02Rp5"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000011" name="dei:EntityRegistrantName">Oruka Therapeutics,
Inc.</ix:nonNumeric></span>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of Registrant as Specified in Its
Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20241003__20241003_zJ0kgbBhDNNe"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityFileNumber_c20241003__20241003_zyuYvXPsboy6"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000013" name="dei:EntityFileNumber">000-22873</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20241003__20241003_zS0skKCKahLc"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000014" name="dei:EntityTaxIdentificationNumber">36-3855489</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(State or Other Jurisdiction<br/>
of Incorporation)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission&#160;File Number)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(IRS Employer<br/>
Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20241003__20241003_zIc3XFYDt5J3"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000015" name="dei:EntityAddressAddressLine1">885 Oak Grove Avenue</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressAddressLine2_c20241003__20241003_zlQYWBxRpRM"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 49%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressCityOrTown_c20241003__20241003_zN2QrAukTGjl"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000017" name="dei:EntityAddressCityOrTown">Menlo Park</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20241003__20241003_z5MglWpxdkwj"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20241003__20241003_zw9fdFHvkIp"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000019" name="dei:EntityAddressPostalZipCode">94025</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(Address of Principal Executive Offices)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(Zip Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s Telephone Number, Including
Area Code: (<span id="xdx_903_edei--CityAreaCode_c20241003__20241003_zedalRu3Iz96"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000020" name="dei:CityAreaCode">650</ix:nonNumeric></span>) <span id="xdx_90A_edei--LocalPhoneNumber_c20241003__20241003_zfHK6AxQNS7d"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000021" name="dei:LocalPhoneNumber">606-7910</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed Since
Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--WrittenCommunications_c20241003__20241003_zD3UjDNiiPE1"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SolicitingMaterial_c20241003__20241003_zUFKv5zrcfxa"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20241003__20241003_z65dUrCzuHQ1"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20241003__20241003_zk7LH9m7PNp5"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(b)
of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20241003__20241003_zsMiUkuCVqI4"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000026" name="dei:Security12bTitle">Common stock, $0.001 Par Value</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20241003__20241003_zr0UeTHJB9Sd"><ix:nonNumeric contextRef="AsOf2024-10-03" id="Fact000027" name="dei:TradingSymbol">ORKA</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">The <span id="xdx_909_edei--SecurityExchangeName_c20241003__20241003_z8SuVhp31UL7"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Market&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20241003__20241003_zIb311BoFR9e"><ix:nonNumeric contextRef="AsOf2024-10-03" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><b>Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 3, 2024, Oruka Therapeutics, Inc. (the
&#8220;Company&#8221;) and each of Lawrence Klein, the Company&#8217;s Chief Executive Officer, and Arjun Agarwal, the Company&#8217;s
Senior Vice President, Finance, entered into amended and restated employment letter agreements (the &#8220;Amended Agreements&#8221;).
In addition to ministerial changes, the Amended Agreements revised each executive&#8217;s potential severance benefits and payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Dr. Klein&#8217;s Amended Agreement, in
the event of a termination without cause or resignation for good reason more than three months prior to or more than 12 months following
a change in control of the Company, he would be eligible to receive: (i) severance payments equal to 12&#160;months of his base salary,
(ii)&#160;accelerated vesting of 30% of the unvested portion of any outstanding time-based&#160;equity awards, and (iii)&#160;Company-subsidized&#160;continuation
coverage under the Company&#8217;s group health plans for up to 12&#160;months; however, if such termination occurs within three months
prior to or within 12 months following a change in control of the Company, he would instead be eligible to receive: (A) severance payments
equal to 1.5 times the sum of his base salary and target bonus, (B) accelerated vesting of all outstanding equity awards (with performance-based
equity awards vesting based on the greater of target or actual performance unless otherwise provided in the applicable award agreement),
and (C) Company-paid continuation coverage under the Company&#8217;s group health plans for up to 18 months. In addition, in the event
of his termination due to death or disability, Dr. Klein&#8217;s Amended Agreement provides for accelerated vesting of all outstanding
time-based equity awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Mr. Agarwal&#8217;s Amended Agreement, in
the event of a termination without cause more than three months prior to or more than 12 months following a change in control of the Company,
he would be eligible to receive: (i) severance payments equal to nine&#160;months of his base salary, and (ii)&#160;Company-subsidized&#160;continuation
coverage under the Company&#8217;s group health plans for up to nine&#160;months; however, if such termination occurs within three months
prior to or within 12 months following a change in control of the Company, he would instead be eligible to receive: (A) severance payments
equal to 0.75 times the sum of his base salary and target bonus, (B) accelerated vesting of all outstanding equity awards (with performance-based
equity awards vesting based on the greater of target or actual performance unless otherwise provided in the applicable award agreement),
and (C) Company-paid continuation coverage under the Company&#8217;s group health plans for up to nine months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Amended Agreements
does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Amended Agreements,
copies of which are attached hereto as Exhibits 10.1 and 10.2 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><b>Item
9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d)&#160;Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 9%; text-align: left"><b>Exhibit<br/> Number</b></td>
    <td style="padding-bottom: 1.5pt; width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 90%; vertical-align: bottom"><b>Description</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">10.1</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><a href="ea021674601ex10-1_oruka.htm">Amended and Restated Employment Letter Agreement by and between the Company and Dr. Lawrence Klein, dated as of October 3, 2024.</a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top">10.2</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><a href="ea021674601ex10-2_oruka.htm">Amended and Restated Employment Letter Agreement by and between the Company and Arjun Agarwal, dated as of October 3, 2024.</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">104</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><b>Oruka Therapeutics, Inc.</b></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 60%">Date: October 4, 2024</td>
    <td style="vertical-align: top; width: 4%">By:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 36%">/s/ Paul Quinlan</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Paul Quinlan<br/> General Counsel</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">2</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OWwzJfAxqYgsRCJ6XXKMJd2R2a3sk/rLNiUaBobh3nOvEBOxobVukOG8LHM4Yts1yiGUWCOjuaB3ZNtdCv6WeNXWsTJueH9gRp5BzyRhFCsvDNaHtlilMJNTOZ9GMcgkjRdQ7EXw1TMyta7QOK0aUKaCgqljjU7xa0w4qp4Mta+h6oRsNRkfF8pRfkMkZxEc6KGexDcLeZ6JYDJMIDZM9867Vr1D8yVh1WDr6+xI/zf4AAdhSo4= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea021674601ex10-1_oruka.htm
<DESCRIPTION>AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN THE COMPANY AND DR. LAWRENCE KLEIN, DATED AS OF OCTOBER 3, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">October 3, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lawrence Klein</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o Oruka Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">855 Oak Grove Avenue, Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Menlo Park, CA 94025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Re: Amended and Restated Employment Letter Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Lawrence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of the Board of Directors (the &ldquo;Board&rdquo;)
of Oruka Therapeutics, Inc. (the &ldquo;<U>Company</U>&rdquo;), I am pleased to offer you a continuing position as Chief Executive Officer
of the Company (&ldquo;<U>CEO</U>&rdquo;) and as a member of the Board pursuant to this letter agreement (the &ldquo;<U>Agreement</U>&rdquo;).
Your position as CEO commenced on February 26, 2024 pursuant to your amended and restated letter agreement dated February 14, 2024. This
Agreement will amend and restate that February 14, 2024 letter agreement provided you accept this offer as indicated by your signature
below, to be effective as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>1. Position</B>.
As CEO, you will report to the Board. You will have such duties, authorities, and responsibilities as are customarily associated with
the CEO role. This is a full-time employment position. You will be a member of the Board until, pursuant to the Company&rsquo;s by-laws,
your successor is elected and duly qualified, or until your earlier death, disability resignation or removal. If at any time the Company,
or any successor entity, is publicly traded while you serve as CEO, you will be nominated for stockholder approval to serve as a member
of the Board. You will also be deemed to have resigned from the Board upon ceasing to serve as CEO for any reason unless the Board agrees
otherwise. It is understood and agreed that, while you are employed by the Company, you will not engage in any other employment, consulting
or other business activities (whether full-time or part-time), except as a director for Nava Therapeutics and Jade Biosciences, Inc.,
or except as expressly authorized in writing by the Board. Notwithstanding the foregoing, you may engage in religious, charitable and
other community activities so long as such activities do not unreasonably interfere or conflict with your obligations to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2. Base
Salary</B>. Upon and following the date hereof, as cash compensation for your services, the Company will pay you an initial base salary
of $600,000 per year, payable in accordance with the Company&rsquo;s standard payroll schedule and subject to applicable deductions and
withholdings. Your base salary will be subject to periodic review and potential adjustment in the Company&rsquo;s discretion. Your base
salary in effect at any given time is referred to herein as the &ldquo;<U>Base Salary</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3. Annual
Bonus</B>. You will continue to be eligible to receive an annual performance bonus targeted at 50% of your Base Salary. The target annual
bonus in effect at any given time is referred to herein as &ldquo;<U>Target Bonus</U>.&rdquo; Your 2024 annual bonus will be prorated
based on your period of employment following February 26, 2024. The actual bonus amount is discretionary and may be subject to achievement
of performance targets established by the Company for such year. To earn an annual bonus, you must be employed by the Company as of the
payment date of such bonus. Any annual bonus will be paid no later than March 15th of the calendar year following the calendar year to
which such bonus relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4. Benefits/Paid
Time Off. </B>You will continue to be eligible, subject to the terms of the applicable plans and programs, to participate in the employee
benefits and insurance programs generally made available to the Company&rsquo;s full-time employees. Details of such benefits programs,
including applicable employee contributions and waiting periods, if applicable, will be made available to you as such benefit(s) become
available. You will be entitled to paid time off consistent with the terms of the Company&rsquo;s paid time off policy, as in effect from
time to time. The Company reserves the right to modify, limit, amend or cancel any of its benefits plans or programs at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5. Expense
Reimbursement. </B>The Company will reimburse you for all reasonable and necessary expenses incurred by you in connection with performing
your duties as a member of the Board and as an employee of the Company and that are pre-approved by the Company, provided that you comply
with any Company policy or practice on incurring, submitting, accounting for and documenting such expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6. Location</B>.
Your primary work location will continue to be in Menlo Park, CA, provided that you may be required to engage in reasonable travel for
business, consistent with the Company&rsquo;s business needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7. At-Will
Employment; Resignation from Subsidiaries</B>. At all times, your employment with the Company is &ldquo;at will,&rdquo; meaning you or
the Company may terminate it at any time for any or no reason, subject to the terms of this Agreement. Although your job duties, title,
reporting structure, compensation and benefits, as well as the Company&rsquo;s benefit plans and personnel policies and procedures, may
change from time to time (subject to the terms of this Agreement), the &ldquo;at will&rdquo; nature of your employment may only be changed
in an express written agreement signed by you and an authorized executive officer of the Company. Your last day of employment for any
reason is referred to herein as the &ldquo;Date of Termination.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent applicable, you shall be deemed
to have resigned from all officer and board member positions that you hold with the Company or any of its respective subsidiaries and
affiliates upon the termination of your employment for any reason. You shall execute any documents in reasonable form as may be requested
to confirm or effectuate any such resignations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>8. Accrued
Obligations</B>. In the event of the ending of your employment for any reason, the Company shall pay you (i) your Base Salary and, if
applicable, any accrued but unused vacation, through the Date of Termination, and (ii) the amount of any documented expenses properly
incurred by you on behalf of the Company prior to any such termination and not yet reimbursed. (the &ldquo;<U>Accrued Obligations</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>9. Severance
Pay and Benefits Outside of the Change in Control Period</B>. If the Company terminates your employment without Cause (and not as a result
of your death or Disability) or you resign with Good Reason, in each case, outside of the Change in Control Period (as such capitalized
terms are defined in&nbsp;<U>Appendix A</U>), then, in addition to the Accrued Obligations, and subject to (i)&nbsp;your execution and&nbsp;non-revocation&nbsp;of
a separation agreement and release in a form acceptable to the Company, which shall include a general release of claims against the Company
and all related persons and entities and a reaffirmation of the Continuing Obligations (as defined below) and shall provide that if you
breach the Continuing Obligations, all payments of the following severance pay and benefits shall immediately cease (the &ldquo;<U>Separation
Agreement and Release</U>&rdquo;), and (ii)&nbsp;the Separation Agreement and Release becoming irrevocable, all within 60 days after the
Date of Termination (or such shorter period as set forth in the Separation Agreement and Release), which shall include a seven-day revocation
period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company shall pay you an amount equal to 12 months of your Base Salary (the &ldquo;<U>Severance Amount</U>&rdquo;),
payable in substantially equal installments over the 12-month period following the Date of Termination in accordance with the Company&rsquo;s
regular payroll practices beginning on the Company&rsquo;s first regularly scheduled payroll date following the date that is 60 days after
the Date of Termination; provided, however, that the first installment shall include any amounts that would have been paid following the
Date of Termination had such installments commenced on the first regularly scheduled payroll date following the Date of Termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary in any applicable equity-based award agreement or plan, 30% of
the unvested portion of your then outstanding equity-based awards subject to time-based vesting (the &ldquo;<U>Time-Based Equity Awards</U>&rdquo;)
as of the Termination Date shall immediately accelerate and become vested or nonforfeitable as of the later of (i)&nbsp;the Date of Termination
or (ii)&nbsp;the effective date of the Separation Agreement and Release (such later date being the &ldquo;<U>Accelerated Vesting Date</U>&rdquo;);
provided that any termination or forfeiture of the unvested portion of such Time-Based Equity Awards that would otherwise occur on the
Date of Termination in the absence of this Agreement will be delayed until the effective date of the Separation Agreement and Release
and will only occur if the vesting pursuant to this subsection does not occur due to the absence of the Separation Agreement and Release
becoming fully effective within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of the Time-Based
Equity Awards shall occur during the period between the Date of Termination and the Accelerated Vesting Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Subject to your copayment of premium amounts at the applicable active employees&rsquo; rate and your proper
election to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&ldquo;<U>COBRA</U>&rdquo;),
the Company shall pay to the group health plan provider(s), the COBRA provider or you a monthly payment equal to the monthly employer
contribution that the Company would have made to provide health insurance to you if you had remained employed by the Company until the
earliest of (A)&nbsp;the&nbsp;12-month&nbsp;anniversary of the Date of Termination; (B)&nbsp;your eligibility for group health plan benefits
under any other employer&rsquo;s group health plan; or (C)&nbsp;the cessation of your continuation rights under COBRA; provided, however,
that if the Company reasonably determines that it cannot pay such amounts to the group health plan provider(s) or the COBRA provider (if
applicable) without potentially violating applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service
Act), then the Company shall convert such payments to payroll payments directly to you for the time period specified above. Such payments,
if to you, shall be subject to&nbsp;tax-related&nbsp;deductions and withholdings and paid on the Company&rsquo;s regular payroll dates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding anything to the contrary in this
Agreement, for the avoidance of doubt:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">if your employment ends as a result of a termination by the Company for Cause or a resignation by you
without Good Reason, you will be entitled to the Accrued Obligations and will not be entitled to any further compensation from the Company;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">if your employment ends due to your death or Disability, (i)&nbsp;you will receive the Accrued Obligations
and (ii)&nbsp;all outstanding Time-Based Equity Awards shall immediately accelerate and become vested or nonforfeitable as of the Date
of Termination, but you will not be eligible for any other severance pay or benefits, whether pursuant to&nbsp;<U>Section&nbsp;9</U>,
<U>Section&nbsp;10</U> or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>10. Severance
Pay and Benefits Within the Change in Control Period</B>. If the Company terminates your employment without Cause (and not as a result
of your death or Disability) or you resign with Good Reason, in each case, within the Change in Control Period, then, in addition to you
being entitled to the Accrued Obligations, and subject to your execution and&nbsp;non-revocation&nbsp;of the Separation Agreement and
Release and it becoming fully effective, all within 60 days after the Date of Termination (or such shorter period as set forth in the
Separation Agreement and Release), which shall include a&nbsp;seven-day&nbsp;revocation period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company shall pay you an amount equal to 1.5 times the sum of (i) your Base Salary and (ii) your Target
Bonus for the year in which the termination occurs (in each case, calculated by reference to your Base Salary rate and Target Bonus as
in effect immediately prior to your termination, but without giving effect to any prior reduction in Base Salary or Target Bonus by the
Company that would give rise to your right to resign for Good Reason) (such salary and bonuses together, the &ldquo;<U>CIC Severance Amount</U>&rdquo;),
payable in substantially equal installments over the 18-month period following the Date of Termination in accordance with the Company&rsquo;s
regular payroll practices beginning on the Company&rsquo;s first regularly scheduled payroll date following the date that is 60 days after
the Date of Termination; provided, however, that the first installment shall include any amounts that would have been paid following the
Date of Termination had such installments commenced on the first regularly scheduled payroll date following the Date of Termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary in any applicable equity-based award agreement or plan, all of
your unvested Time-Based Equity Awards shall immediately accelerate and become vested or nonforfeitable as of the Accelerated Vesting
Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">All of your outstanding equity-based awards subject to performance-based vesting (the &ldquo;<U>Performance-Based
Equity Awards</U>&rdquo;) shall immediately accelerate and become vested or nonforfeitable as of the Accelerated Vesting Date with the
performance criteria being deemed to have been met based on the greater of target or, if determinable, actual performance; provided, however,
that the applicable award agreement for any Performance-Based Equity Award may provide for alternative treatment upon a termination covered
by this&nbsp;<U>Section&nbsp;10.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The Company shall pay to the group health plan provider(s), the COBRA provider or you a monthly payment
equal to the monthly COBRA continuation premiums until the earliest of (A)&nbsp;the&nbsp;18-month&nbsp;anniversary of the Date of Termination;
(B)&nbsp;your eligibility for group health plan benefits under any other employer&rsquo;s group health plan; or (C)&nbsp;the cessation
of your continuation rights under COBRA; provided, however, that if the Company reasonably determines that it cannot pay such amounts
to the group health plan provider(s) or the COBRA provider (if applicable) without potentially violating applicable law (including, without
limitation, Section&nbsp;2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly
to you for the time period specified above. Such payments, if to you, shall be subject to&nbsp;tax-related&nbsp;deductions and withholdings
and paid on the Company&rsquo;s regular payroll dates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the avoidance of doubt,&nbsp;<U>Section&nbsp;9</U>&nbsp;and&nbsp;<U>Section&nbsp;10</U>&nbsp;of
this Agreement are mutually exclusive and in no event shall you be entitled to payments or benefits pursuant to both&nbsp;<U>Section&nbsp;9</U>&nbsp;and&nbsp;<U>Section&nbsp;10</U>&nbsp;of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>11. Continuing
Obligations</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B>Business Protection Agreement</B>. You have previously entered into an Invention Assignment, Non-Disclosure
and Business Protection Agreement (the &ldquo;<U>Business Protection Agreement</U>&rdquo;). For purposes of this Agreement, the obligations
in this <U>Section 11</U> and those that arise in the Business Protection Agreement and any other agreement relating to confidentiality,
assignment of inventions, or other restrictive covenants shall collectively be referred to as the &ldquo;<U>Continuing Obligations</U>.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B>Third Party Agreements and Rights</B>. You hereby confirm that you are not bound by the terms of any
agreement with any previous employer or other party that would prevent you from performing your obligations hereunder. You represent to
the Company that your execution of this Agreement, your employment with the Company and the performance of your proposed duties for the
Company will not violate any obligations you may have to any such previous employer or other party. In your work for the Company, you
will not disclose or make use of any information in violation of any agreements with or rights of any such previous employer or other
party, and you will not bring to the premises of the Company or load or access on any electronic system of the Company, any copies or
other tangible embodiments of non-public information belonging to or obtained from any such previous employment or other party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><B>Litigation and Regulatory Cooperation</B>. You shall reasonably cooperate with the Company in (i) the
defense or prosecution of any claims or actions now in existence or that may be brought in the future against or on behalf of the Company
that relate to events or occurrences that transpired while you were engaged or employed by the Company, and (ii) the investigation, whether
internal or external, of any matters about which the Company believes you may have knowledge or information. Your full cooperation in
connection with such claims, actions or investigations shall include, but not be limited to, being reasonably available to meet with counsel
to answer questions or to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually convenient times.
During and after your engagement and employment, you also shall reasonably cooperate with the Company in connection with any investigation
or review of any federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that
transpired while you were employed by the Company. The Company shall reimburse you for any reasonable out-of-pocket expenses incurred
in connection with your performance of obligations pursuant to this <U>Section 11(c)</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><B>Relief</B>. You agree that it would be difficult to measure any damages caused to the Company that
might result from your breach of any of the Continuing Obligations, and that in any event money damages may be an inadequate remedy for
any such breach. Accordingly, you agree that if you breach, or propose to breach, any portion of the Continuing Obligations, the Company
shall be entitled, in addition to all other remedies that it may have, to seek an injunction or other appropriate equitable relief to
restrain any such breach without showing or proving any actual damage to the Company or posting any bond.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>12. Golden
Parachute Taxes</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B>Best&nbsp;After-Tax&nbsp;Result</B>. In the event that any payment or benefit received or to be received
by you pursuant to this Agreement or otherwise (&ldquo;<U>Payments</U>&rdquo;) would (i)&nbsp;constitute a &ldquo;parachute payment&rdquo;
within the meaning of Section&nbsp;280G of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), and (ii)&nbsp;but
for this subsection (a), be subject to the excise tax imposed by Section&nbsp;4999 of the Code, any successor provisions, or any comparable
federal, state, local or foreign excise tax (&ldquo;<U>Excise Tax</U>&rdquo;), then, subject to the provisions of Section&nbsp;14, such
Payments shall be either (A)&nbsp;provided in full pursuant to the terms of this Agreement or any other applicable agreement, or (B)&nbsp;provided
as to such lesser extent that would result in the Payments being $1.00 less than the amount at which any portion of the Payments would
be subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state, local and foreign
income, employment and other taxes and the Excise Tax (including, without limitation, any interest or penalties on such taxes), results
in the receipt, on an&nbsp;after-tax&nbsp;basis, of the greatest amount of payments and benefits provided for hereunder or otherwise,
notwithstanding that all or some portion of such Payments may be subject to the Excise Tax. Unless the Company and you otherwise agree
in writing, any determination required under this Section shall be made by independent tax counsel designated by the Company and reasonably
acceptable to you (&ldquo;<U>Independent Tax Counsel</U>&rdquo;), whose determination shall be conclusive and binding upon you and the
Company for all purposes. For purposes of making the calculations required under this Section, Independent Tax Counsel may make reasonable
assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application
of Sections 280G and 4999 of the Code; provided that Independent Tax Counsel shall assume that you pay all taxes at the highest marginal
rate. The Company and you shall furnish to Independent Tax Counsel such information and documents as Independent Tax Counsel may reasonably
request in order to make a determination under this Section. The Company shall bear all costs that Independent Tax Counsel may reasonably
incur in connection with any calculations contemplated by this Section. In the event that&nbsp;<U>Section&nbsp;13(a)(ii)(B)</U>&nbsp;above
applies, then based on the information provided to you and the Company by Independent Tax Counsel, the cutback described hereunder will
apply as to compensation not subject to Section&nbsp;409A of the Code prior to compensation subject to Section&nbsp;409A of the Code and
will otherwise apply on a reverse chronological basis from payments latest in time. If the Internal Revenue Service (the &ldquo;<U>IRS</U>&rdquo;)
determines that any Payment is subject to the Excise Tax, then&nbsp;<U>Section&nbsp;12(b)</U>&nbsp;hereof shall apply, and the enforcement
of&nbsp;<U>Section&nbsp;12(b)</U>&nbsp;shall be the exclusive remedy to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B>Adjustments</B>. If, notwithstanding any reduction described in&nbsp;<U>Section&nbsp;12(a)</U>&nbsp;hereof
(or in the absence of any such reduction), the IRS determines that you are liable for the Excise Tax as a result of the receipt of one
or more Payments, then you shall be obligated to surrender or pay back to the Company within&nbsp;one-hundred&nbsp;120 days after a final
IRS determination, an amount of such payments or benefits equal to the &ldquo;<U>Repayment Amount</U>.&rdquo; The Repayment Amount with
respect to such Payments shall be the smallest such amount, if any, as shall be required to be surrendered or paid to the Company so that
your net proceeds with respect to such Payments (after taking into account the payment of the Excise Tax imposed on such Payments) shall
be maximized. Notwithstanding the foregoing, the Repayment Amount with respect to such Payments shall be zero if a Repayment Amount of
more than zero would not eliminate the Excise Tax imposed on such Payments or if a Repayment Amount of more than zero would not maximize
the net amount received from the Payments. If the Excise Tax is not eliminated pursuant to this&nbsp;<U>Section&nbsp;12(b)</U>, you shall
pay the Excise Tax.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>13. Section
409A</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Anything in this Agreement to the contrary notwithstanding, if at the time of your separation from service
within the meaning of Section&nbsp;409A of the Code, the Company determines that you are a &ldquo;specified employee&rdquo; within the
meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that you become entitled to under this
Agreement or otherwise on account of your separation from service would be considered deferred compensation otherwise subject to the additional
tax imposed pursuant to Section&nbsp;409A(a) of the Code as a result of the application of Section&nbsp;409A(a)(2)(B)(i) of the Code,
such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A)&nbsp;six months and
one day after your separation from service, or (B)&nbsp;your death. If any such delayed cash payment is otherwise payable on an installment
basis, the first payment shall include a&nbsp;catch-up&nbsp;payment covering amounts that would otherwise have been paid during the&nbsp;six-month&nbsp;period
but for the application of this provision (without interest), and the balance of the installments shall be payable in accordance with
their original schedule.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">All&nbsp;in-kind&nbsp;benefits provided and expenses eligible for reimbursement under this Agreement shall
be provided by the Company or incurred by you during the time periods set forth in this Agreement. All reimbursements shall be paid as
soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following
the taxable year in which the expense was incurred. The amount of&nbsp;in-kind&nbsp;benefits provided or reimbursable expenses incurred
in one taxable year shall not affect the&nbsp;in-kind&nbsp;benefits to be provided or the expenses eligible for reimbursement in any other
taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or&nbsp;in-kind&nbsp;benefits
is not subject to liquidation or exchange for another benefit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">To the extent that any payment or benefit described in this Agreement constitutes&nbsp;&ldquo;non-qualified&nbsp;deferred
compensation&rdquo; under Section&nbsp;409A of the Code, and to the extent that such payment or benefit is payable upon the termination
of your employment, then such payments or benefits shall be payable only upon your &ldquo;separation from service.&rdquo; The determination
of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation&nbsp;Section&nbsp;1.409A-l(h).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The parties intend that this Agreement will be administered in accordance with Section&nbsp;409A of the
Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section&nbsp;409A of the Code, the provision
shall be read in such a manner so that all payments hereunder comply with Section&nbsp;409A of the Code. Each payment pursuant to this
Agreement is intended to constitute a separate payment for purposes of Treasury Regulation&nbsp;Section&nbsp;1.409A-2(b)(2).&nbsp;The
parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with
Section&nbsp;409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder
without additional cost to either party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">The Company makes no representation or warranty and shall have no liability to you or any other person
if any provisions of this Agreement are determined to constitute deferred compensation subject to Section&nbsp;409A of the Code but do
not satisfy an exemption from, or the conditions of, such Section.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>14. Withholding;
Tax Effect</B>. All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable withholding and
payroll taxes and other deductions required by law. You hereby acknowledge that the Company does not have a duty to design its compensation
policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or the Board related to
tax liabilities arising from your compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>15. Recoupment</B>.
Amounts paid or payable under this Agreement shall be subject to the provisions of any applicable clawback or recoupment policies or procedures
adopted by the Company, which clawback or recoupment policies may provide for forfeiture and/or recoupment of amounts paid or payable
under this Agreement. No forfeiture or recoupment under such policies or procedures will give rise to a right to resign for Good Reason
under this Agreement or under any other agreement between you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>16. Interpretation
and Enforcement</B>. This Agreement, together with <U>Appendix A</U>, the Business Protection Agreement and any award agreement between
you and the Company constitute the complete agreement between you and the Company, contains all of the terms of your employment with the
Company and supersedes any prior agreements, representations or understandings (whether written, oral or implied) between you and the
Company. The terms of this Agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this Agreement
or arising out of, related to, or in any way connected with this Agreement, your employment with the Company or any other relationship
between you and the Company (the &ldquo;<U>Disputes</U>&rdquo;) will be governed by federal law to the extent applicable and otherwise
by California law, excluding laws relating to conflicts or choice of law and excluding Disputes arising in connection with any equity
incentive plan, which shall be governed by the terms of the applicable equity incentive plan. You and the Company submit to the exclusive
personal jurisdiction of the federal and state courts located in the County of San Mateo and State of California in connection with any
Dispute or any claim related to any Dispute, except for Disputes arising under any equity incentive plan, which shall be governed by the
terms of the applicable equity incentive plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>17. Assignment</B>.
Neither you nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without
the prior written consent of the other; <I>provided, however</I>, that the Company may assign its rights and obligations under this Agreement
without your consent to any affiliate or to any person or entity with whom the Company shall hereafter effect a reorganization, consolidate
with, or merge into or to whom it transfers all or substantially all of its properties or assets; provided further, that if you remain
employed or become employed by the Company, the purchaser or any of their affiliates in connection with any such transaction, then you
shall not be entitled to any payments, benefits or vesting pursuant to <U>Section 9</U> or pursuant to <U>Section 10</U> of this Agreement
solely as a result of such transaction. This Agreement shall inure to the benefit of and be binding upon you and the Company, and each
of your and its respective successors, executors, administrators, heirs and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>18. Waiver;
Amendment</B>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure
of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this
Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. This
Agreement may be amended or modified only by a written instrument signed by you and by a duly authorized executive officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>19. Enforceability</B>.
If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement)
shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or
the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable,
shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>20. Conditions</B>.
You must submit satisfactory proof of your identity, successfully complete a criminal background check, which you hereby expressly authorize
by your execution of this Agreement, and provide documentation of your legal authorization to work in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>21. Employee
Representations</B>. It is the policy of the Company not to solicit or accept proprietary information and/or trade secrets of other companies
or third parties. If you have or have had access to trade secrets or other confidential, proprietary information from your former employer
or another third party, the use of such information in performing your duties at the Company is prohibited. This may include, but is not
limited to, confidential or proprietary information in the form of documents, magnetic media, software, customer lists, and business plans
or strategies. In making this employment offer, the Company has relied on your representation that: (a) you are not currently a party
to any agreement that would restrict your ability to accept this offer or to perform services for the Company; (b) you are not subject
to any noncompetition or non-solicitation agreement or other restrictive covenants that might restrict your employment by the Company
as contemplated by this offer; (c) you have the full right, power and authority to execute and deliver the Agreement and to perform all
of your obligations thereunder; and (d) you will not bring with you to the Company or use in the performance of your responsibilities
at the Company any materials, documents or work product of a former employer or other third party that are not generally available to
the public, unless you have obtained written authorization from such former employer or third party for their possession and use and have
provided the Company with a copy of same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>22. Other
Terms</B>. The provisions of this Agreement shall survive the termination of this Agreement and/or the termination of your employment
to the extent necessary to effectuate the terms contained herein. The headings and other captions in this Agreement are for convenience
and reference only and shall not be used in interpreting, construing or enforcing any of the provisions of this Agreement. This Agreement
may be executed in separate counterparts. When both counterparts are signed, they shall be treated together as one and the same document.
PDF copies of signed counterparts shall be equally effective as originals. This Agreement may also be executed electronically by any means
that satisfies applicable electronic signature laws (e.g., DocuSign).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To indicate your acceptance of the Company&rsquo;s
amended and restated offer, please sign this Agreement in the space provided below and return it to me. If you have any questions regarding
this letter agreement, feel free to contact me.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I look forward to working with you to make the
Company a great success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sincerely,</FONT></TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Samarth Kulkarni</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Samarth Kulkarni</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chair of the Board</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accepted and acknowledged:</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Lawrence Klein</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lawrence Klein</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Appendix A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">&ldquo;<U>Cause</U>&rdquo; shall mean (i)&nbsp;your dishonest
statements or acts with respect to the Company or any affiliate of the Company, or any current or prospective customers, suppliers, vendors
or other third parties with which such entity does business that results in or is reasonably anticipated to result in material harm to
the Company; (ii)&nbsp;your conviction or plea of no contest to: (A)&nbsp;a felony or (B)&nbsp;any misdemeanor involving moral turpitude,
deceit, dishonesty or fraud; (iii)&nbsp;your failure to perform in all material respects your lawful assigned duties and responsibilities
to the reasonable satisfaction of the Board, which failure continues, in the reasonable judgment of the Board, for 30 days after written
notice given to you describing such failure; (iv)&nbsp;your gross negligence, willful misconduct that results in or is reasonably anticipated
to result in material harm to the Company; or (v)&nbsp;your violation of any material violation of any agreement(s) between you and the
Company or any written Company policies including, without limitation, agreements relating to&nbsp;non-solicitation,&nbsp;non-disclosure&nbsp;and/or
assignment of inventions or policies related to ethics or workplace conduct.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">&ldquo;<U>Change in Control</U>&rdquo; shall have the meaning
set forth in the Company&rsquo;s 2024 Stock Incentive Plan (or the meaning provided to any word of similar import under any successor
plan).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">&ldquo;<U>Change in Control Period</U>&rdquo; shall mean
the period commencing three months prior to the first event constituting a Change in Control and ending 12 months following the first
event constituting a Change in Control.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">&ldquo;<U>Disability</U>&rdquo; shall mean a permanent and
total disability as defined in Section&nbsp;22(e)&nbsp;(3) of the Code.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">&ldquo;<U>Good Reason</U>&rdquo; shall mean that you have
complied with the Good Reason Process (hereinafter defined) following the occurrence, without your written consent, of any of the following
events: (i)&nbsp;a material diminution in your base salary or Target Bonus except for&nbsp;across-the-board&nbsp;salary and target bonus
reductions of no more than 10% based on the Company&rsquo;s financial performance similarly affecting all or substantially all senior
management employees of the Company; (ii)&nbsp;a material change in the geographic location at which you are required to provide services
to the Company or a requirement that you change your remote location from your then-current residence; (iii)&nbsp;a material reduction
in your duties, authority or responsibilities; (iv)&nbsp;the failure of the Company to obtain the assumption of this Agreement by a successor;
or (v)&nbsp;the material breach of this Agreement (or any other agreements with you) by the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">6.</TD><TD STYLE="text-align: justify">&ldquo;<U>Good Reason Process</U>&rdquo; shall mean that
(i)&nbsp;you reasonably determine in good faith that a &ldquo;Good Reason&rdquo; condition has occurred; (ii)&nbsp;you notify the Company
in writing of the first occurrence of the Good Reason condition within 60 days of the first occurrence of such condition; (iii)&nbsp;you
cooperate in good faith with the Company&rsquo;s efforts, for a period not less than 30 days following such notice (the &ldquo;<U>Cure
Period</U>&rdquo;), to remedy the condition; (iv)&nbsp;notwithstanding such efforts, the Good Reason condition continues to exist; and
(v)&nbsp;you terminate your employment within 30 days after the end of the Cure Period. If the Company cures the Good Reason condition
during the Cure Period, Good Reason shall be deemed not to have occurred.</TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea021674601ex10-2_oruka.htm
<DESCRIPTION>AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN THE COMPANY AND ARJUN AGARWAL, DATED AS OF OCTOBER 3, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">October 3, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Arjun Agarwal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o Oruka Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">855 Oak Grove Avenue, Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Menlo Park, CA 94025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Re: Amended and Restated Employment Letter Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Arjun:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of Oruka Therapeutics, Inc. (the &ldquo;<U>Company</U>&rdquo;),
I am pleased to offer you a continuing position as Senior Vice President, Finance (the &ldquo;<U>Role</U>&rdquo;) pursuant to this letter
agreement (the &ldquo;<U>Agreement</U>&rdquo;). Your Role commenced on March 22, 2024 pursuant to your letter agreement dated March 11,
2024. This Agreement will amend and restate that March 11, 2024 letter agreement, provided you accept this offer as indicated by your
signature below, to be effective as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>1. Position</B>.
While serving in the Role, you will initially report to the Company&rsquo;s Chief Executive Officer. You will have such duties, authorities,
and responsibilities as are customarily associated with the Role. This is a full-time employment position. It is understood and agreed
that, on and after the date hereof, you will not engage in any other employment, consulting or other business activities (whether full-time
or part-time), except as expressly authorized in writing by the Company. Notwithstanding the foregoing, you may engage in religious, charitable
and other community activities so long as such activities do not unreasonably interfere or conflict with your obligations to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2. Base
Salary</B>. On and after the date hereof, as cash compensation for your services, the Company will pay you an initial base salary of $360,000
per year, payable in accordance with the Company&rsquo;s standard payroll schedule and subject to applicable deductions and withholdings.
Your base salary will be subject to periodic review and potential adjustment in the Company&rsquo;s discretion. Your base salary in effect
at any given time is referred to herein as the &ldquo;<U>Base Salary</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3. Annual
Bonus</B>. You will continue to be eligible to receive an annual performance bonus targeted at 35% of your Base Salary. The target annual
bonus in effect at any given time is referred to herein as &ldquo;<U>Target Bonus</U>.&rdquo; Your 2024 annual bonus will be based on
an effective date of January 1, 2024. The actual bonus amount is discretionary and may be subject to achievement of performance targets
established by the Company for such year. To earn an annual bonus, you must be employed by the Company as of the payment date of such
bonus. Any annual bonus will be paid no later than March 15th of the calendar year following the calendar year to which such bonus relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4. Benefits/Paid
Time Off. </B>You will continue to be eligible, subject to the terms of the applicable plans and programs, to participate in the employee
benefits and insurance programs generally made available to the Company&rsquo;s full-time employees. Details of such benefits programs,
including applicable employee contributions and waiting periods, if applicable, will be made available to you as such benefit(s) become
available. You will be entitled to paid time off consistent with the terms of the Company&rsquo;s paid time off policy, as in effect from
time to time. The Company reserves the right to modify, limit, amend or cancel any of its benefits plans or programs at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5. Expense
Reimbursement. </B>The Company will reimburse you for all reasonable and necessary expenses incurred by you in connection with performing
your duties as an employee of the Company and that are pre-approved by the Company, provided that you comply with any Company policy or
practice on incurring, submitting, accounting for and documenting such expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6. Location</B>.
Your primary work location will continue to be in Menlo Park, CA, provided that you may be required to engage in reasonable travel for
business, consistent with the Company&rsquo;s business needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7. At-Will
Employment; Resignation from Subsidiaries</B>. At all times, your employment with the Company is &ldquo;at will,&rdquo; meaning you or
the Company may terminate it at any time for any or no reason, subject to the terms of this Agreement. Although your job duties, title,
reporting structure, compensation and benefits, as well as the Company&rsquo;s benefit plans and personnel policies and procedures, may
change from time to time (subject to the terms of this Agreement), the &ldquo;at will&rdquo; nature of your employment may only be changed
in an express written agreement signed by you and an authorized executive officer of the Company. Your last day of employment for any
reason is referred to herein as the &ldquo;Date of Termination.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent applicable, you shall be deemed
to have resigned from all officer and board member positions that you hold with the Company or any of its respective subsidiaries and
affiliates upon the termination of your employment for any reason. You shall execute any documents in reasonable form as may be requested
to confirm or effectuate any such resignations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>8. Accrued
Obligations</B>. In the event of the ending of your employment for any reason, the Company shall pay you (i) your Base Salary and, if
applicable, any accrued but unused vacation, through the Date of Termination, and (ii) the amount of any documented expenses properly
incurred by you on behalf of the Company prior to any such termination and not yet reimbursed. (the &ldquo;<U>Accrued Obligations</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>9. Severance
Pay and Benefits Outside of the Change in Control Period</B>. If the Company terminates your employment without Cause (and not as a result
of your death or Disability) outside of the Change in Control Period (as such capitalized terms are defined in&nbsp;<U>Appendix A</U>),
then, in addition to the Accrued Obligations, and subject to (i)&nbsp;your execution and&nbsp;non-revocation&nbsp;of a separation agreement
and release in a form acceptable to the Company, which shall include a general release of claims against the Company and all related persons
and entities and a reaffirmation of the Continuing Obligations (as defined below) and shall provide that if you breach the Continuing
Obligations, all payments of the following severance pay and benefits shall immediately cease (the &ldquo;<U>Separation Agreement and
Release</U>&rdquo;), and (ii)&nbsp;the Separation Agreement and Release becoming irrevocable, all within 60 days after the Date of Termination
(or such shorter period as set forth in the Separation Agreement and Release), which shall include a seven-day revocation period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company shall pay you an amount equal to nine months of your Base Salary (the &ldquo;<U>Severance
Amount</U>&rdquo;), payable in substantially equal installments over the nine-month period following the Date of Termination in accordance
with the Company&rsquo;s regular payroll practices beginning on the Company&rsquo;s first regularly scheduled payroll date following the
date that is 60 days after the Date of Termination; provided, however, that the first installment shall include any amounts that would
have been paid following the Date of Termination had such installments commenced on the first regularly scheduled payroll date following
the Date of Termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Subject to your copayment of premium amounts at the applicable active employees&rsquo; rate and your proper
election to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&ldquo;<U>COBRA</U>&rdquo;),
the Company shall pay to the group health plan provider(s), the COBRA provider or you a monthly payment equal to the monthly employer
contribution that the Company would have made to provide health insurance to you if you had remained employed by the Company until the
earliest of (A)&nbsp;the&nbsp;nine-month&nbsp;anniversary of the Date of Termination; (B)&nbsp;your eligibility for group health plan
benefits under any other employer&rsquo;s group health plan; or (C)&nbsp;the cessation of your continuation rights under COBRA; provided,
however, that if the Company reasonably determines that it cannot pay such amounts to the group health plan provider(s) or the COBRA provider
(if applicable) without potentially violating applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service
Act), then the Company shall convert such payments to payroll payments directly to you for the time period specified above. Such payments,
if to you, shall be subject to&nbsp;tax-related&nbsp;deductions and withholdings and paid on the Company&rsquo;s regular payroll dates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding anything to the contrary in this
Agreement, for the avoidance of doubt, if your employment ends as a result of a termination by the Company for Cause, you will be entitled
to the Accrued Obligations and will not be entitled to any further compensation from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>10. Severance
Pay and Benefits Within the Change in Control Period</B>. If the Company terminates your employment without Cause (and not as a result
of your death or Disability) within the Change in Control Period, then, in addition to you being entitled to the Accrued Obligations,
and subject to your execution and&nbsp;non-revocation&nbsp;of the Separation Agreement and Release and it becoming fully effective, all
within 60 days after the Date of Termination (or such shorter period as set forth in the Separation Agreement and Release), which shall
include a&nbsp;seven-day&nbsp;revocation period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company shall pay you an amount equal 0.75 times the sum of (i) your Base Salary and (ii) your Target
Bonus for the year in which the termination occurs (in each case, calculated by reference to your Base Salary rate and Target Bonus as
in effect immediately prior to your termination (such salary and bonuses together, the &ldquo;<U>CIC Severance Amount</U>&rdquo;), payable
in substantially equal installments over the nine-month period following the Date of Termination in accordance with the Company&rsquo;s
regular payroll practices beginning on the Company&rsquo;s first regularly scheduled payroll date following the date that is 60 days after
the Date of Termination; provided, however, that the first installment shall include any amounts that would have been paid following the
Date of Termination had such installments commenced on the first regularly scheduled payroll date following the Date of Termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary in any applicable equity-based award agreement or plan, all of
the unvested portion of your then outstanding equity-based awards subject to time-based vesting (the &ldquo;<U>Time-Based Equity Awards</U>&rdquo;)
as of the Termination Date shall immediately accelerate and become vested or nonforfeitable as of the later of (i)&nbsp;the Date of Termination
or (ii)&nbsp;the effective date of the Separation Agreement and Release (such later date being the &ldquo;<U>Accelerated Vesting Date</U>&rdquo;);
and provided further that any termination or forfeiture of the unvested portion of such Time-Based Equity Awards that would otherwise
occur on the Date of Termination in the absence of this Agreement will be delayed until the effective date of the Separation Agreement
and Release and will only occur if the vesting pursuant to this subsection does not occur due to the absence of the Separation Agreement
and Release becoming fully effective within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of
the Time-Based Equity Awards shall occur during the period between the Date of Termination and the Accelerated Vesting Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">All of your outstanding equity-based awards subject to performance-based vesting (the &ldquo;<U>Performance-Based
Equity Awards</U>&rdquo;) shall immediately accelerate and become vested or nonforfeitable as of the Accelerated Vesting Date with the
performance criteria being deemed to have been met based on the greater of target or, if determinable, actual performance; provided, however,
that the applicable award agreement for any Performance-Based Equity Award may provide for alternative treatment upon a termination covered
by this&nbsp;<U>Section&nbsp;10.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The Company shall pay to the group health plan provider(s), the COBRA provider or you a monthly payment
equal to the monthly COBRA continuation premiums until the earliest of (A)&nbsp;the&nbsp;nine-month&nbsp;anniversary of the Date of Termination;
(B)&nbsp;your eligibility for group health plan benefits under any other employer&rsquo;s group health plan; or (C)&nbsp;the cessation
of your continuation rights under COBRA; provided, however, that if the Company reasonably determines that it cannot pay such amounts
to the group health plan provider(s) or the COBRA provider (if applicable) without potentially violating applicable law (including, without
limitation, Section&nbsp;2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly
to you for the time period specified above. Such payments, if to you, shall be subject to&nbsp;tax-related&nbsp;deductions and withholdings
and paid on the Company&rsquo;s regular payroll dates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the avoidance of doubt,&nbsp;<U>Section&nbsp;9</U>&nbsp;and&nbsp;<U>Section&nbsp;10</U>&nbsp;of
this Agreement are mutually exclusive and in no event shall you be entitled to payments or benefits pursuant to both&nbsp;<U>Section&nbsp;9</U>&nbsp;and&nbsp;<U>Section&nbsp;10</U>&nbsp;of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>11. Continuing
Obligations</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B>Business Protection Agreement</B>. You have previously entered into an Invention Assignment, Non-Disclosure
and Business Protection Agreement (the &ldquo;<U>Business Protection Agreement</U>&rdquo;). For purposes of this Agreement, the obligations
in this <U>Section 11</U> and those that arise in the Business Protection Agreement and any other agreement relating to confidentiality,
assignment of inventions, or other restrictive covenants shall collectively be referred to as the &ldquo;<U>Continuing Obligations</U>.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B>Third Party Agreements and Rights</B>. You hereby confirm that you are not bound by the terms of any
agreement with any previous employer or other party that would prevent you from performing your obligations hereunder. You represent to
the Company that your execution of this Agreement, your employment with the Company and the performance of your proposed duties for the
Company will not violate any obligations you may have to any such previous employer or other party. In your work for the Company, you
will not disclose or make use of any information in violation of any agreements with or rights of any such previous employer or other
party, and you will not bring to the premises of the Company or load or access on any electronic system of the Company, any copies or
other tangible embodiments of non-public information belonging to or obtained from any such previous employment or other party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><B>Litigation and Regulatory Cooperation</B>. You shall reasonably cooperate with the Company in (i) the
defense or prosecution of any claims or actions now in existence or that may be brought in the future against or on behalf of the Company
that relate to events or occurrences that transpired while you were engaged or employed by the Company, and (ii) the investigation, whether
internal or external, of any matters about which the Company believes you may have knowledge or information. Your full cooperation in
connection with such claims, actions or investigations shall include, but not be limited to, being reasonably available to meet with counsel
to answer questions or to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually convenient times.
During and after your engagement and employment, you also shall reasonably cooperate with the Company in connection with any investigation
or review of any federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that
transpired while you were employed by the Company. The Company shall reimburse you for any reasonable out-of-pocket expenses incurred
in connection with your performance of obligations pursuant to this <U>Section 11(c)</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><B>Relief</B>. You agree that it would be difficult to measure any damages caused to the Company that
might result from your breach of any of the Continuing Obligations, and that in any event money damages may be an inadequate remedy for
any such breach. Accordingly, you agree that if you breach, or propose to breach, any portion of the Continuing Obligations, the Company
shall be entitled, in addition to all other remedies that it may have, to seek an injunction or other appropriate equitable relief to
restrain any such breach without showing or proving any actual damage to the Company or posting any bond.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>12. Golden
Parachute Taxes</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B>Best&nbsp;After-Tax&nbsp;Result</B>. In the event that any payment or benefit received or to be received
by you pursuant to this Agreement or otherwise (&ldquo;<U>Payments</U>&rdquo;) would (i)&nbsp;constitute a &ldquo;parachute payment&rdquo;
within the meaning of Section&nbsp;280G of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), and (ii)&nbsp;but
for this subsection (a), be subject to the excise tax imposed by Section&nbsp;4999 of the Code, any successor provisions, or any comparable
federal, state, local or foreign excise tax (&ldquo;<U>Excise Tax</U>&rdquo;), then, subject to the provisions of Section&nbsp;14, such
Payments shall be either (A)&nbsp;provided in full pursuant to the terms of this Agreement or any other applicable agreement, or (B)&nbsp;provided
as to such lesser extent that would result in the Payments being $1.00 less than the amount at which any portion of the Payments would
be subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state, local and foreign
income, employment and other taxes and the Excise Tax (including, without limitation, any interest or penalties on such taxes), results
in the receipt, on an&nbsp;after-tax&nbsp;basis, of the greatest amount of payments and benefits provided for hereunder or otherwise,
notwithstanding that all or some portion of such Payments may be subject to the Excise Tax. Unless the Company and you otherwise agree
in writing, any determination required under this Section shall be made by independent tax counsel designated by the Company and reasonably
acceptable to you (&ldquo;<U>Independent Tax Counsel</U>&rdquo;), whose determination shall be conclusive and binding upon you and the
Company for all purposes. For purposes of making the calculations required under this Section, Independent Tax Counsel may make reasonable
assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application
of Sections 280G and 4999 of the Code; provided that Independent Tax Counsel shall assume that you pay all taxes at the highest marginal
rate. The Company and you shall furnish to Independent Tax Counsel such information and documents as Independent Tax Counsel may reasonably
request in order to make a determination under this Section. The Company shall bear all costs that Independent Tax Counsel may reasonably
incur in connection with any calculations contemplated by this Section. In the event that&nbsp;<U>Section&nbsp;13(a)(ii)(B)</U>&nbsp;above
applies, then based on the information provided to you and the Company by Independent Tax Counsel, the cutback described hereunder will
apply as to compensation not subject to Section&nbsp;409A of the Code prior to compensation subject to Section&nbsp;409A of the Code and
will otherwise apply on a reverse chronological basis from payments latest in time. If the Internal Revenue Service (the &ldquo;<U>IRS</U>&rdquo;)
determines that any Payment is subject to the Excise Tax, then&nbsp;<U>Section&nbsp;12(b)</U>&nbsp;hereof shall apply, and the enforcement
of&nbsp;<U>Section&nbsp;12(b)</U>&nbsp;shall be the exclusive remedy to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B>Adjustments</B>. If, notwithstanding any reduction described in&nbsp;<U>Section&nbsp;12(a)</U>&nbsp;hereof
(or in the absence of any such reduction), the IRS determines that you are liable for the Excise Tax as a result of the receipt of one
or more Payments, then you shall be obligated to surrender or pay back to the Company within&nbsp;one-hundred&nbsp;120 days after a final
IRS determination, an amount of such payments or benefits equal to the &ldquo;<U>Repayment Amount</U>.&rdquo; The Repayment Amount with
respect to such Payments shall be the smallest such amount, if any, as shall be required to be surrendered or paid to the Company so that
your net proceeds with respect to such Payments (after taking into account the payment of the Excise Tax imposed on such Payments) shall
be maximized. Notwithstanding the foregoing, the Repayment Amount with respect to such Payments shall be zero if a Repayment Amount of
more than zero would not eliminate the Excise Tax imposed on such Payments or if a Repayment Amount of more than zero would not maximize
the net amount received from the Payments. If the Excise Tax is not eliminated pursuant to this&nbsp;<U>Section&nbsp;12(b)</U>, you shall
pay the Excise Tax.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>13. Section
409A</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Anything in this Agreement to the contrary notwithstanding, if at the time of your separation from service
within the meaning of Section&nbsp;409A of the Code, the Company determines that you are a &ldquo;specified employee&rdquo; within the
meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that you become entitled to under this
Agreement or otherwise on account of your separation from service would be considered deferred compensation otherwise subject to the additional
tax imposed pursuant to Section&nbsp;409A(a) of the Code as a result of the application of Section&nbsp;409A(a)(2)(B)(i) of the Code,
such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A)&nbsp;six months and
one day after your separation from service, or (B)&nbsp;your death. If any such delayed cash payment is otherwise payable on an installment
basis, the first payment shall include a&nbsp;catch-up&nbsp;payment covering amounts that would otherwise have been paid during the&nbsp;six-month&nbsp;period
but for the application of this provision (without interest), and the balance of the installments shall be payable in accordance with
their original schedule.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">All&nbsp;in-kind&nbsp;benefits provided and expenses eligible for reimbursement under this Agreement shall
be provided by the Company or incurred by you during the time periods set forth in this Agreement. All reimbursements shall be paid as
soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following
the taxable year in which the expense was incurred. The amount of&nbsp;in-kind&nbsp;benefits provided or reimbursable expenses incurred
in one taxable year shall not affect the&nbsp;in-kind&nbsp;benefits to be provided or the expenses eligible for reimbursement in any other
taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or&nbsp;in-kind&nbsp;benefits
is not subject to liquidation or exchange for another benefit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">To the extent that any payment or benefit described in this Agreement constitutes&nbsp;&ldquo;non-qualified&nbsp;deferred
compensation&rdquo; under Section&nbsp;409A of the Code, and to the extent that such payment or benefit is payable upon the termination
of your employment, then such payments or benefits shall be payable only upon your &ldquo;separation from service.&rdquo; The determination
of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation&nbsp;Section&nbsp;1.409A-l(h).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The parties intend that this Agreement will be administered in accordance with Section&nbsp;409A of the
Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section&nbsp;409A of the Code, the provision
shall be read in such a manner so that all payments hereunder comply with Section&nbsp;409A of the Code. Each payment pursuant to this
Agreement is intended to constitute a separate payment for purposes of Treasury Regulation&nbsp;Section&nbsp;1.409A-2(b)(2).&nbsp;The
parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with
Section&nbsp;409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder
without additional cost to either party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">The Company makes no representation or warranty and shall have no liability to you or any other person
if any provisions of this Agreement are determined to constitute deferred compensation subject to Section&nbsp;409A of the Code but do
not satisfy an exemption from, or the conditions of, such Section.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>14. Withholding;
Tax Effect</B>. All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable withholding and
payroll taxes and other deductions required by law. You hereby acknowledge that the Company does not have a duty to design its compensation
policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or the Board related to
tax liabilities arising from your compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>15. Recoupment</B>.
Amounts paid or payable under this Agreement shall be subject to the provisions of any applicable clawback or recoupment policies or procedures
adopted by the Company, which clawback or recoupment policies may provide for forfeiture and/or recoupment of amounts paid or payable
under this Agreement. No forfeiture or recoupment under such policies or procedures will give rise to a right to resign for good reason
under this Agreement or under any other agreement between you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>16. Interpretation
and Enforcement</B>. This Agreement, together with <U>Appendix A</U>, the Business Protection Agreement and any award agreement between
you and the Company constitute the complete agreement between you and the Company, contains all of the terms of your employment with the
Company and supersedes any prior agreements, representations or understandings (whether written, oral or implied) between you and the
Company. The terms of this Agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this Agreement
or arising out of, related to, or in any way connected with this Agreement, your employment with the Company or any other relationship
between you and the Company (the &ldquo;<U>Disputes</U>&rdquo;) will be governed by federal law to the extent applicable and otherwise
by California law, excluding laws relating to conflicts or choice of law and excluding Disputes arising in connection with any equity
incentive plan, which shall be governed by the terms of the applicable equity incentive plan. You and the Company submit to the exclusive
personal jurisdiction of the federal and state courts located in the County of San Mateo and State of California in connection with any
Dispute or any claim related to any Dispute, except for Disputes arising under any equity incentive plan, which shall be governed by the
terms of the applicable equity incentive plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>17. Assignment</B>.
Neither you nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without
the prior written consent of the other; <I>provided, however</I>, that the Company may assign its rights and obligations under this Agreement
without your consent to any affiliate or to any person or entity with whom the Company shall hereafter effect a reorganization, consolidate
with, or merge into or to whom it transfers all or substantially all of its properties or assets; provided further, that if you remain
employed or become employed by the Company, the purchaser or any of their affiliates in connection with any such transaction, then you
shall not be entitled to any payments, benefits or vesting pursuant to <U>Section 9</U> or pursuant to <U>Section 10</U> of this Agreement
solely as a result of such transaction. This Agreement shall inure to the benefit of and be binding upon you and the Company, and each
of your and its respective successors, executors, administrators, heirs and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>18. Waiver;
Amendment</B>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure
of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this
Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. This
Agreement may be amended or modified only by a written instrument signed by you and by a duly authorized executive officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>19. Enforceability</B>.
If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement)
shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or
the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable,
shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>20. Conditions</B>.
You must submit satisfactory proof of your identity, successfully complete a criminal background check, which you hereby expressly authorize
by your execution of this Agreement, and provide documentation of your legal authorization to work in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>21. Employee
Representations</B>. It is the policy of the Company not to solicit or accept proprietary information and/or trade secrets of other companies
or third parties. If you have or have had access to trade secrets or other confidential, proprietary information from your former employer
or another third party, the use of such information in performing your duties at the Company is prohibited. This may include, but is not
limited to, confidential or proprietary information in the form of documents, magnetic media, software, customer lists, and business plans
or strategies. In making this employment offer, the Company has relied on your representation that: (a) you are not currently a party
to any agreement that would restrict your ability to accept this offer or to perform services for the Company; (b) you are not subject
to any noncompetition or non-solicitation agreement or other restrictive covenants that might restrict your employment by the Company
as contemplated by this offer; (c) you have the full right, power and authority to execute and deliver the Agreement and to perform all
of your obligations thereunder; and (d) you will not bring with you to the Company or use in the performance of your responsibilities
at the Company any materials, documents or work product of a former employer or other third party that are not generally available to
the public, unless you have obtained written authorization from such former employer or third party for their possession and use and have
provided the Company with a copy of same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>22. Other
Terms</B>. The provisions of this Agreement shall survive the termination of this Agreement and/or the termination of your employment
to the extent necessary to effectuate the terms contained herein. The headings and other captions in this Agreement are for convenience
and reference only and shall not be used in interpreting, construing or enforcing any of the provisions of this Agreement. This Agreement
may be executed in separate counterparts. When both counterparts are signed, they shall be treated together as one and the same document.
PDF copies of signed counterparts shall be equally effective as originals. This Agreement may also be executed electronically by any means
that satisfies applicable electronic signature laws (e.g., DocuSign).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To indicate your acceptance of the Company&rsquo;s
offer, please sign this Agreement in the space provided below and return it to me. If you have any questions regarding this letter agreement,
feel free to contact me.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I look forward to working with you to make the
Company a great success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sincerely,</FONT></TD>
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Lawrence Klein</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lawrence Klein</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accepted and acknowledged:</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Arjun Agarwal</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Arjun Agarwal</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Appendix A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">&ldquo;<U>Cause</U>&rdquo; shall mean (i)&nbsp;your dishonest
statements or acts with respect to the Company or any affiliate of the Company, or any current or prospective customers, suppliers, vendors
or other third parties with which such entity does business that results in or is reasonably anticipated to result in material harm to
the Company; (ii)&nbsp;your conviction or plea of no contest to: (A)&nbsp;a felony or (B)&nbsp;any misdemeanor involving moral turpitude,
deceit, dishonesty or fraud; (iii)&nbsp;your failure to perform in all material respects your lawful assigned duties and responsibilities
to the reasonable satisfaction of the Board, which failure continues, in the reasonable judgment of the Board, for 30 days after written
notice given to you describing such failure; (iv)&nbsp;your gross negligence, willful misconduct that results in or is reasonably anticipated
to result in material harm to the Company; or (v)&nbsp;your violation of any material violation of any agreement(s) between you and the
Company or any written Company policies including, without limitation, agreements relating to&nbsp;non-solicitation,&nbsp;non-disclosure&nbsp;and/or
assignment of inventions or policies related to ethics or workplace conduct.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">&ldquo;<U>Change in Control</U>&rdquo; shall have the meaning
set forth in the Company&rsquo;s 2024 Stock Incentive Plan (or the meaning provided to any word of similar import under any successor
plan).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">&ldquo;<U>Change in Control Period</U>&rdquo; shall mean
the period commencing three months prior to the first event constituting a Change in Control and ending 12 months following the first
event constituting a Change in Control.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">&ldquo;<U>Disability</U>&rdquo; shall mean a permanent and
total disability as defined in Section&nbsp;22(e)&nbsp;(3) of the Code.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex10-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !M 2$# 2(  A$! Q$!_\0
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MI<7 P/,DB!)QTSZ_C6JJJBA5 50,  8 %+10VWN"26J"BBBD,**** "BBB@
MHHHH ****  @'K2  = !2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex10-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !M 2$# 2(  A$! Q$!_\0
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MI<7 P/,DB!)QTSZ_C6JJJBA5 50,  8 %+10VWN"26J"BBBD,**** "BBB@
MHHHH ****  @'K2  = !2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>orka-20241003.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaCKKaPtyJ1xOYkxuG9wffk63yor/2LFNiGGX3U2QWsN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ORKA="http://orukatx.com/20241003" elementFormDefault="qualified" targetNamespace="http://orukatx.com/20241003">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://orukatx.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="orka-20241003_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="orka-20241003_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>orka-20241003_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>orka-20241003_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://orukatx.com/role/Cover" xlink:href="orka-20241003.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://orukatx.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45054541677488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 03, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  03,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-22873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Oruka Therapeutics,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000907654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-3855489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">885 Oak Grove Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Menlo Park<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">606-7910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.001 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ORKA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *V 1%D'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "M@$193[[FN.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>.DT'AZCK96BG(2$Q"<0M2KPMHDFCQ*C=VY.6K1."!^ 8^\_G
MSY(;':3N(S['/F DB^EN=)U/4H<U.Q$%"9#T"9U*94[XW#STT2G*SWB$H/2'
M.B((SA_ (2FC2,$$+,)"9&UCM-01%?7Q@C=ZP8?/V,TPHP$[=.@I0556P-II
M8CB/70,WP 0CC"Y]%] LQ+GZ)W;N +LDQV27U# ,Y5#/N;Q#!6]/NY=YW<+Z
M1,IKS+^2E70.N&;7R:_UYG&_9:W@8E54O."KO>"2WTM1OT^N/_QNPJXW]F#_
ML?%5L&W@UUVT7U!+ P04    " "M@$19F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *V 1%G%]'B68 0  !L1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9A=<^HV$(;O^RLT;J?3SB3Q!]\I,$-(TF9R$FB@Y\RTTPMA"]!@2ZXD!_CW
M71EBT]2LN0'+>%\_WEV_DNAOI=KH-6.&[))8Z(&S-B:]=5T=KEE"]8U,F8!?
MEE(EU,!0K5R=*D:C/"B)W<#SVFY"N7"&_?S<5 W[,C,Q%VRJB,Z2A*K]'8OE
M=N#XSL>)-[Y:&WO"'?93NF(S9OY(IPI&;J$2\80)S:4@BBT'SLB_O0M:-B"_
MXBMG6WUR3.RC+*3<V,%3-' \2\1B%AHK0>'KG8U9'%LEX/CG*.H4][2!I\<?
MZH_YP\/#+*AF8QE_XY%9#YRN0R*VI%ELWN3V-W9\H!PPE+'./\GV<&VSZ9 P
MTT8FQV @2+@X?-/=,1$G 0W_3$!P# AR[L.-<LI[:NBPK^26*'LUJ-F#_%'S
M:(#CPE9E9A3\RB'.#,?RG:F^:T#*GG##8]C=(2PX$S8)S0WQ&E<D\(+F?\-=
M("@P@@(CR/4:& ;Y:[301D&A_JXB.B@TJQ5L]][JE(9LX$![:J;>F3/\\7N_
M[?V"\#4*O@:F/KR780:]:,A\G[(J.#R\>_V,0#0+B":J,@*"**=XC.FJB@*/
M7])8,X2C57"T+DO&E"DN(_(@(@+-5YD77"EOH[R/ZAJI7;"U4<4'8;C9DT<>
M,_*:)8OJYL8U/,^[#H)NIX'P= J>SB4\;VS%;6M#TEYI4IDI7&>BL@TE\S53
M-&69X:&^^NY)A#<(8K= [%Z".(:**AJ3)Q&Q'7EF^RI(7 D2Y_6\3KN%5;)7
M8/4NP9K3'7F*@(TO>4AS)S]?5URQT;YN=%NM9K>'X/E>Z9S>)8!0!:E2J7*V
M*S(S\"80J<A89I!0R*N,*NM=HW[_@$&>V+M_">0HBL 4]=7' ?D"UY&)J";#
M);O=%IG0#?E5@6F3T3L3&>8J?CD'^*B%XZSSK:QDQ25G&8=J^)Z' 9:3@(_;
M^&? L1U!J>=R*RKA<+D7)F))IE1M,+IR=O!Q>_],5W3B% K%15A=:UQS/,+0
MR@G#QWW^,]I4:@-6\R=/S[\>N&*OZ04MC*V<,'S<[?,BCF!%>QX%%VBWT.XJ
M9PH?M_@O,H2<3-=28%-7C4C;:U]W>CY*5$X,/N[GWQ0WA@E(3))DXFB_NI(*
M%ZI;>?CEI.#C'CZ3,0^YX6)%7J"]%:=Q)0^N4L<3E)- @-OT5+'K$-+#X/TZ
M+!!AC09+V<ER65V_&KU:LM+Y ]RF_T?VI'4&9+6 N&PMX,F2'_?F.3>P2)-+
MX@<_+7XF,Q9FT&^5RXX:)=N?L"Z S5*XN2(_>#>>YUM?)5]IC,Y-06G] >[5
M<T4CVW2S?;*0E2U7(S!Y>\:\-"AM/L M^2-/Y&$7KJE8L;,KRAJAU]'L?O0[
MQE3Z>W"1OS\D3*ULEF!IL#5KZQLI%=45Q07/=IE[LM6U?QN\4'M'36*V!"'O
MI@.ZZK 3/PR,3//=[T(:V$OGAVM&X0VP%\#O2RG-Q\!NJ(O_0X;_ E!+ P04
M    " "M@$19GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0
M_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=
M/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M
M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQN
MZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX
M_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)
MWMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBM
MNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,
MX_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*
M'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1
MJP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF
M<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>
M(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>
MN$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM
M0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'
M$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[
M*CG_5U/\!%!+ P04    " "M@$19EXJ[',     3 @  "P   %]R96QS+RYR
M96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY
M/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL
M/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%
MY4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.
MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( *V 1%FJQ"(6,P$  "("   /
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *V 1%DD'INBK0   /@!   :
M          "  <@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( *V 1%EED'F2&0$  ,\#   3              "  :T2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /<3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0216746-8k_oruka.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://orukatx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0216746-8k_oruka.htm">ea0216746-8k_oruka.htm</File>
    <File>orka-20241003.xsd</File>
    <File>orka-20241003_lab.xml</File>
    <File>orka-20241003_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0216746-8k_oruka.htm": {
   "nsprefix": "ORKA",
   "nsuri": "http://orukatx.com/20241003",
   "dts": {
    "inline": {
     "local": [
      "ea0216746-8k_oruka.htm"
     ]
    },
    "schema": {
     "local": [
      "orka-20241003.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "orka-20241003_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "orka-20241003_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://orukatx.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-10-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0216746-8k_oruka.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-10-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0216746-8k_oruka.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://orukatx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-24-085543-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-085543-xbrl.zip
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M7+^[[7R0ZZ?5ZC7\0L)(*O7,P3GI#J=X%YK:73"UYT/)'\\&K3&Z4+ICH"E
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M]#B2P6]6%%_8Z8STRO\!4$L#!!0    ( *V 1%G/&;#SCC(  %;Z   ;
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M""8UA;U!VQV:UMM9^%O1<97B+\@%B*8ZF+![[),8,->= Y!^CC-$&R??L$5
MYV\'9?)D"D&;$YA#6<@"R< %Y@34UM"_T6Y!9P[<2_9&I&"<)BWN,'Y&5\YN
MTJTCKD=3]:I,=. 99-=QE:W(F"JK]V#"\P\&&3Y021QO&CHH43<K4!\R4:)#
MUX*CS*;2YW#GX1B R8MO93+(JWJ./.N)*8Q);]\Q_0O4W6;O%]C_\<C'NIYB
M ,SY%\GM]JZ=U5F:Z0JN)9M71PW=_X9?R_Y*;U)T-Q3-!;%J-+OL)]:261E=
MX(7  \4#"I_" T;Q07Y&8-:1=]/Z^.#_BE*.^RK] *;@H@8P_[Q9ENU"7$"_
ME3/G@B;9!E*87==T5YNJ3=#?/XG]'WBGK?0@H75AT(]9#Y,2_S#43$Q5(R?,
MF;$0QV.%)3$IO W&A T8CQ(P-8"FV?\9B$&U<[/%[DY"OX#LO]U^#F0XJS8X
M0]S\LLCIBO$44E1-B.NR5Y"\@'"!@G"*^&IGUNF3DJWF78?&!;E*#G)U&+=X
M0G)=HW6VZ5FJ=.1X-N37O8D?Y$1LO#.A(W2W?"%'R)>)=Y[QX<-7N$6AWD?^
M^Z5FI8W=ZG"_!OWJ^"-[(D36)&=%]MH(2>U9+WK*^K?<WDA6K#!T(_&P.N ?
M[&[3\+(<8S8U>_(M_68VK-$GR-BISRHI+X^IRM"W5LC6'2& &@:21B T3-W(
MCJ!7.(/OT?=-6F>K93B2TT&\Y?8)@6^!&29)U>)6O/:N<&;SIV(DG>,!R%4U
M[-R_]H1B;S"?E'4'[V2[/3<:$@;:+D < 1&3-L?S W&,KOT6/5KGFK4'?$E%
MC!Q?-G#9.8RXD\$+R49D]Q7\)B06XDRBL +_!<Z,"F!7=2V[R *G&(+=59&[
MRU),2,JD&)=P;TSCM>BTAR:00U#1&03A]]M&=X^G\,"Y(2-[/'JC66FW[@'U
MNFV 97C%GH4@W.D7:/^6N7I#UJZ0:7P>3F>H!S63$LCHA08R4COV;,C4@&O>
MYNRG9#,$ Z_($TY<Z'57<<Q#6 *SP.\Q7/A6:!X-5PT4D !A3U1YLU7 1,0*
M3_0Z:V"W_B#.1 (=39@4-J6@T)N<$=#+>HTW\5(=(9FPD.?WZS1EA(;H!0.4
M->E&1N!"\LB\82RFF7CY\Z(L]BIS+DH[?U;B756U6>M*2-TI AR[)Q@,34GX
M+P$L!IPF%%U%7RAQ"7: 8!!>?"YN*-C')-<9[LI"9T7=A(/ 9%#A(+,TI\@T
MJUBL5Y'7PBI9>-@H@JJ5$S<\D /H!)M%IV-/@! ?#+@1EL9V"<O&C$@'S(R*
MB&#[F!,E[)!EE;S?.XQK>S6(98::IMVC%8AS%*"@H26T-QU^\LX=2PB787P;
M;6:,6[)<DD\6A_(#J,'GV4V$D\TJI@QFV# YO!9PZH_V48F#'9^SRQSN^0"'
M5CO6RU^#FHB_E# %W@E#4@4NF;CKKIO4[C9*P@TM]E"G]%0\'O&;/AWRC?Y[
MD!6#;$\^S(K4X.![^].'6=%3$\^.CE^]5"]>OGKUYNCDY/2G[_]];_\>_?WN
MS=$+^_<OIR=G/_S[WL'^_C_N?>R<!1$]X+LF'_6SL[=V9*#%!@1R;A<$#R*\
M^]G9B?W%198V2WB0E_3L_MG)\ZW?[NC=[@^&-=NMZ@,:%2S(#<)GD)D<'*H5
MK']9#T7H^G?#WJXC&B:Z"A0?LN%GU%P;32%=N&C\-N0[\*?<W',F;9C 'DW
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M,CCHI[+8.\GJ)"]K*EA.<;2K7MBU1*^979"@KI 'P?5=E^C"[8'.63,N0P"
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MU<>9>G6@GCS<W7]T.SCHO7FJ#M:F2$VJ=)&J]Z9N= -_O%YO\O("OFG4&].
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MHS\50^^F'@,5T-T]L8Q,PDO2*S&X HSA,_[M9NK3,N.$4^"IM&P7S4R$5(1
M@="N0[R)L,@(,!Q(<R.X*DCJ#A(M", > 85DSR4+O).=06.WE<V4#O)S*=)T
MBQ.9]W8OQQY_8[#C1N&.9U?/B055#S D^,H@-X>[/P8C,K16=TREZ\.'U\*9
M*(FJ\7 39D-=^(13@IS8=[XNYJ2^'N1D<ZY@VKQ*!SSQG[<!??I+F_]?''W:
MG7_WB%,;B%UJ< O06AR)67%PB;[AO&O))W>*@3)ZL?"%>*H7Z4R2MJK1<E$$
M,2<:)3U0)VES6R5&46[CC=]X#LX!"=.^@?$I7"^)<B&X[,)5-%(XERT^07YI
ME'F,9"A/J/ G2B5 A^/HE9>DZA+@C>;R#9&WT9P>3![XILB;&@?>1B&HKX&\
MJ<N M^GD&R)O8SMX@X&W_P I>DT0Y5-,96+$($OY7RV8,CM<9*+/,,/$9PYA
M:FV.1.%4%#X:+3A8-<7],!4K\&_)(\-0K)U&?^PZR@4#2LN7."(^T8D?X%[L
MO*1?O*:QU &-$DHSL(U<8"\\)\3+_2 >QD9SXZ0S)TXK61&EK16@(I:&"Q>#
M$A0N(F&5X[W\P4@;0@%1C*]?M7,MBXPE/[^8'F2+L9>B( M*U3^$C#BKD$;/
MV(!TV9K6P^!LW,!(INW$*ABB@"2AC6TZS6YLBT(A1R#*68:)RZ18K8P:41CD
MMRUJ(UY;,U (3KE3N494R<%(GT!E)D=H^-*HE%G',Q3$Q?)EKV@>M:9@B6D)
M @3]!GXR;5W4/5K$=68R9GN'CD8$3S@CNN$\NRL+=HO2N2&@Y^WR[-$>W4P^
M1W:!E1U8IK$PS9DQXWO*B=_DV@RRZ@W6,3<UN//@+KAS%]SY\^R2Y'IVR0&9
M#5*3?WW#(*@YO=P^>!?\D,36=#)J)WQ)6V!,D#D'A^K?7=UL4F6@8#,M^INS
M?I5-^B7K?PV2W!;Z"DQOK,$AQ<AE1="E1?PE#8@+?8.W#;DIW)VB%SOK6'LV
M4[1'U4@94+*NC0-Q51%,""7]*59UP*QI,$H@CB'4!#U)W"/"4K/:)=E% 8"]
MW3ENV\U5"?\!QSO]=\";+Q[%G$X&PYC\=!14DWAQ'1J%7R.T.)U\8FRQ&V7^
M0J%%#T]?/[:HOGQHT44[/B.VJ+YT:'$Z^?S8HOK"H44BS&?&%M67#BV*#W@7
M6X2W_'T\/#BLE9Z0*2$R(AW37/Y'[%%%CBMFF*];5-?HVIT#W];<KX0:,(%C
MQ@4=O-<<'^H4;MLLYBHH@0X<4U .JZ\U^]L7;MR;CR6-4QCQ+EQT$\-%L'$O
M;?GONPHT1!+#*;Y=$)G6&^SF5+;8[HR:]%)M!T79U5&!IXT>KK&0C-,&?BF+
MG<.L3O*R;BMI6W;I"[L>R16S"_LGH@R"X[LI,9;3P[G80@H:F5&PAG[C3Z[:
MV\,Q!6"!@031J[+:M<NX?/I<#6J-$>\+D%(1!)D*\5)6QF#A8#3:D8SJ"BTI
M@9M<ISILT%AEC%ZAX5_HPA55)*!<&-C*I>[/UXOV&E\-%XO$/;#N7(6;'J%X
MC@TJ,O >W^D*/4G+:&RFO">#-3B\<%3!2;05H*["%54H)<V V>GR"5V%-54A
MZP HEEX15@HX6]MSZ89F$T#5^%M\F(PV3+GQK2[ZK05QFF1D\ZPK@Q78AI1Q
MG.)I%Q#F; R<^"LK]BV0&H(+U@/ '-<2G77IQ2$FYW02-05!ZK$US2')<#FV
M?0.)SK!P\BH"4DDJ38*:2%ACUQ6=P5>8."*O3UF^4N_&M?YH5,L59]22H*!U
MV4B V/U,+2* YQLB#@PASH[\X(KY3B<TX9E-#0[RL*H@7D9^I!/+42UU7FK"
MAA [ J%:<D"-$HNKL@"/HKZH&[/N/,DELTFYP9W!C@I,O487W+_.K!=EFKDB
M-4SCV;"#$E($B^+@ 9XG+FG1<(HMEXN/+-]&\L(-N[DB\Z8"[@_O /<[P/W&
M ^Z@9M]DC4ATB26C3]^4%?9,PBH([1H !<T: M@GD5_ULW50(F]QR?YTDH+-
M5K 0!\U3!UJ-)!U7#Y.<9.52E&?4(NR<VOLDAM$@W=C>#PMJ&.#ZJRY;BC[;
M\N.R&BWT%VR;41!J-W1JO62*5U**ED!83:6+>D-]B<ZHB36I .PCS#V*2+*/
MU"MT>A9D%! 72F-JHF']0JV),;:*(YWS?\\L64".PR<U CYM$Z2>60*#@,?>
MFQU5_!%HEYOTA&@6Z /IRX*Q8K=KK#BILB/JV,55[[0K,[<G-%RPC#K.69I1
M;P=)4B90C4STF80Q IZ)6M2MC1'3!9MMU28G% P(#X16U.##OIP*2C HSH$$
M- PP1$!Z%IP';+Q;L%.02%8N#%N(VAWN^H ,93$6PNN*C PR/,OSZ>208]>^
M.3*;7+3YSA\*FW"3U9G7Y:>>DR[]^>. UI0E(LV&A3N6)L4J_)GBUO9D;"14
ME>^.L&U]?L&MUBYL)E@PL/+C2G/2RP\%[,[XJ1@^"G$[/TN97K>Y$$XV&/_;
M*9<[FS+Y"/S1ZS9'[FV7:FS8QL9N:+'VTC(BUYB$YJ\O;K"Q\Q^@N*X92@+%
M]1Z%W])K)K+U7>B!W3/,^\FP)1+6:)"LT37I">P;H]=PBK&W>5O[=/K0!9M.
MUM1M4FH\R&HF%I-&$G(.+^U2,?-M#"69CAW&=5D8/P=1:M0H7:<8OFH0YEB;
M]();WKFSRZ^F=C]@),++\@N1.L'RPW87,U&Y&X)[2O<I=T.LO&\YOH)(>[K8
M@L6:>[4*E/HCH X&SX. D-51U*NU-N8C+_GWMDBL+!)D"5L];BH,O'/TGV1"
M15M.[C+A15I(&E#&Q8/J%>>I\NI/)<W1!L"9\-U-+ZE/5F-_NRB+]!N',[XY
MK+T_5S^6.4@=+*&I@(#8@^M8GYL[6/MFP]K _TR? S1,=F#+^,_W)*P&.G^Y
MY$U7,.WB0K:X.14KBS!6_H2R+U":]'3G09CVZU(VPTKF=Q*!BM)J6#"[I%CL
MX ERA#J_611WXQA1IBH/NVHB"NM+STF077'0]OO='ZU .[+&]7M#%Y/!0>>N
M3WM/OG\<UU]W0>3TTD8\"XP;,VX5)W?"#LXZ#?)I!\X3I$VCSU6V9M@-R!K-
M^^&3)T^\($ZE:QI(-L2-K!"K'6K.^- :2465&;$Q.!-3D'-S#7!/.(5@BU[S
MI\ ]\7*Y"*VS"C^%'M7W'LZDR;[==!^$-AF)=)=-X=**82?)&8E9:[0'IFM-
M:#6$2TSRD"BF/KSLO(<ROE'?4'8T4--4MM-B@.2*DA?N<JM@W^6_]N:[N_2L
MHFL!*!;,U4;:.F8#"M6-(FU3^HSAZ2_E:IAJX?M.21ZN39R ?=$?^1(E\G*H
M.W$W36N8$Y!_A16H%JY<PU<!X.<OW&E0^#OHV$_PRKIL]EDP;,8>.%CL.B=L
MN2RDHQX.#=S%M+8A*A$V&WL=D@2>2:PU5JPM=)W5,TL9SG:#U_A6@"[<'77E
M\BGL,"&'OT<2:S:=%+TD:,VM<;$>$7/\NEGL;F/[]V'$1)NK7PMAFQB6IUZ$
M3F@2!Q,YY&(EIJ;+W>,T'=LCV7:>R&I["/UAH\X+"]R(U& K.N)RV#SQK6%(
M;H,Y<'L&]8:S_BH<FJ@K'#5\]'+C*!@>>>,5#Q\+D3,*,<:+<!/%MAA!2L,B
M8])3'J#M.QO%(VQ'<AL#[4=$UWPX*.5)2N](6%U".+Q[;W EM+,4;O ^*04R
MV_7&Y\N0F7J>K>5%N"90.)W$(W^@UM3G#(L&PK:F,W6"EX,M=4;5K4"M366:
M_I#!.7?)7+*,6I':PW=T]8A/Y6*V'ELO;PPMT/@(&K6YPQ[1O 86-BOPBO#P
ML6V$%]X@KA%[^9;'>=AE"TNH5\A(H^]G9,)'+\)NZU1L?]E.A8PK;6%1E!..
M3HX?[J3N\&*?'8:0B@56?G(8NK;%>->="J$58_A.Q*.8D(?BV)_,<%8]0VXD
M)^<!V!]HI8 .#%)X,%U,&K+*/5U%G#P<DMUS2QF>0X\Y7HRMGAW%I&T6&*X
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M 'O7E8JO"!E3L@[<]V5,M@FKU2C^W2"E+GDY^KC[Z.)B<E%W(H6'W/DNG>&
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M5D6F\<D9YRJ340%_UKTF=C 0@Y;)JLPXXHDOY-B6??+0[9H0>R3;GWN84TD
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M(YKDZ"+=\NZ_?'OX3]K$GXY_?O/B_P-02P,$%     @ K8!$67M#8G0H P
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M#)]<@OXO<&S8([J@&'Q;"S1AHJ:6OP%02P,$%     @ K8!$69E4*:S^"@
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MB$/@T1D9-'Z244B%55?"O)#TC:5;FF->O$O.;2,3H'-+#F"S38PF"H@4NS.
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M4$L! A0#%     @ K8!$6>/MG\(@%0  8W<  !8              ( !
M &5A,#(Q-C<T-BTX:U]O<G5K82YH=&U02P$"% ,4    " "M@$19SQFP\XXR
M  !6^@  &P              @ %4%0  96$P,C$V-S0V,#%E>#$P+3%?;W)U
M:V$N:'1M4$L! A0#%     @ K8!$65RW[6_Q+@  Y>0  !L
M ( !&T@  &5A,#(Q-C<T-C Q97@Q,"TR7V]R=6MA+FAT;5!+ 0(4 Q0    (
M *V 1%E[0V)T* ,  . +   1              "  45W  !O<FMA+3(P,C0Q
M,# S+GAS9%!+ 0(4 Q0    ( *V 1%F95"FL_@H  ("&   5
M  "  9QZ  !O<FMA+3(P,C0Q,# S7VQA8BYX;6Q02P$"% ,4    " "M@$19
M"Y5??%0'  #35P  %0              @ '-A0  ;W)K82TR,#(T,3 P,U]P
<<F4N>&UL4$L%!@     &  8 FP$  %2-      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ea0216746-8k_oruka_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="orka-20241003.xsd" xlink:type="simple"/>
    <context id="AsOf2024-10-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
        </entity>
        <period>
            <startDate>2024-10-03</startDate>
            <endDate>2024-10-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-10-03" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-10-03" id="Fact000004">0000907654</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-10-03" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-10-03" id="Fact000010">2024-10-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-10-03" id="Fact000011">Oruka Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-10-03" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-10-03" id="Fact000013">000-22873</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-10-03" id="Fact000014">36-3855489</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-10-03" id="Fact000015">885 Oak Grove Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-10-03" id="Fact000016">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-10-03" id="Fact000017">Menlo Park</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-10-03" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-10-03" id="Fact000019">94025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-10-03" id="Fact000020">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-10-03" id="Fact000021">606-7910</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-10-03" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-10-03" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-10-03" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-10-03" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-10-03" id="Fact000026">Common stock, $0.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-10-03" id="Fact000027">ORKA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-10-03" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-10-03" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
